New concepts in antibody-mediated immunity

Arturo Casadevall, Liise-anne Pirofski

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

The field of AMI is experiencing a renaissance. The engines driving the field are the application of hybridoma technology to understanding the mechanisms of AMI, the revolution in antibody engineering, and the availability of mice with defined genetic defects, which provide model systems to study Ab efficacy in the setting of immune deficiency. Since the presence of Abs remains the only reliable correlate of immunity to many infectious diseases (68), a better understanding of the parameters that influence AMI is likely to enhance our understanding of vaccine efficacy and host susceptibility to infection. Hence, the beginning of the 21st century resembles the beginning of the 20th century, when AMI promised, and delivered, great benefits to humankind in the form of serum therapy and new vaccines.

Original languageEnglish (US)
Pages (from-to)6191-6196
Number of pages6
JournalInfection and Immunity
Volume72
Issue number11
DOIs
StatePublished - Nov 2004

Fingerprint

Active Immunotherapy
Hybridomas
Communicable Diseases
Immunity
Vaccines
Technology
Antibodies
Infection
Serum
Renaissance

ASJC Scopus subject areas

  • Immunology

Cite this

New concepts in antibody-mediated immunity. / Casadevall, Arturo; Pirofski, Liise-anne.

In: Infection and Immunity, Vol. 72, No. 11, 11.2004, p. 6191-6196.

Research output: Contribution to journalArticle

Casadevall, Arturo ; Pirofski, Liise-anne. / New concepts in antibody-mediated immunity. In: Infection and Immunity. 2004 ; Vol. 72, No. 11. pp. 6191-6196.
@article{71b9e41c8fbd44a592e60d5adb5a43a1,
title = "New concepts in antibody-mediated immunity",
abstract = "The field of AMI is experiencing a renaissance. The engines driving the field are the application of hybridoma technology to understanding the mechanisms of AMI, the revolution in antibody engineering, and the availability of mice with defined genetic defects, which provide model systems to study Ab efficacy in the setting of immune deficiency. Since the presence of Abs remains the only reliable correlate of immunity to many infectious diseases (68), a better understanding of the parameters that influence AMI is likely to enhance our understanding of vaccine efficacy and host susceptibility to infection. Hence, the beginning of the 21st century resembles the beginning of the 20th century, when AMI promised, and delivered, great benefits to humankind in the form of serum therapy and new vaccines.",
author = "Arturo Casadevall and Liise-anne Pirofski",
year = "2004",
month = "11",
doi = "10.1128/IAI.72.11.6191-6196.2004",
language = "English (US)",
volume = "72",
pages = "6191--6196",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "11",

}

TY - JOUR

T1 - New concepts in antibody-mediated immunity

AU - Casadevall, Arturo

AU - Pirofski, Liise-anne

PY - 2004/11

Y1 - 2004/11

N2 - The field of AMI is experiencing a renaissance. The engines driving the field are the application of hybridoma technology to understanding the mechanisms of AMI, the revolution in antibody engineering, and the availability of mice with defined genetic defects, which provide model systems to study Ab efficacy in the setting of immune deficiency. Since the presence of Abs remains the only reliable correlate of immunity to many infectious diseases (68), a better understanding of the parameters that influence AMI is likely to enhance our understanding of vaccine efficacy and host susceptibility to infection. Hence, the beginning of the 21st century resembles the beginning of the 20th century, when AMI promised, and delivered, great benefits to humankind in the form of serum therapy and new vaccines.

AB - The field of AMI is experiencing a renaissance. The engines driving the field are the application of hybridoma technology to understanding the mechanisms of AMI, the revolution in antibody engineering, and the availability of mice with defined genetic defects, which provide model systems to study Ab efficacy in the setting of immune deficiency. Since the presence of Abs remains the only reliable correlate of immunity to many infectious diseases (68), a better understanding of the parameters that influence AMI is likely to enhance our understanding of vaccine efficacy and host susceptibility to infection. Hence, the beginning of the 21st century resembles the beginning of the 20th century, when AMI promised, and delivered, great benefits to humankind in the form of serum therapy and new vaccines.

UR - http://www.scopus.com/inward/record.url?scp=7044231869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7044231869&partnerID=8YFLogxK

U2 - 10.1128/IAI.72.11.6191-6196.2004

DO - 10.1128/IAI.72.11.6191-6196.2004

M3 - Article

C2 - 15501743

AN - SCOPUS:7044231869

VL - 72

SP - 6191

EP - 6196

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 11

ER -